The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Vol.
35
No.
4
January 30, 2009Jan 30, 2009
Free
DOWNLOAD THE PDF

Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

Government Offers Two Approval Standards For Assays: CLIA, FDA

FDA Ponders Standards For “Retrospective Prospective” Studies

ODAC Discussion: NCI’s Richard Simon Cautions About Rules Of Thumb

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account